私が代表を務めるプロアクティブコンサルティングでは、”Proactive Quality Assurance in Medical Science” を理念に掲げ、QMSを医薬系企業の経営や研究開発における中核的な概念として位置づけ、提案しています。今後も、日本の製薬・医療系企業の研究開発力の向上、そしてグローバルな公衆衛生(Public Health)の改善に貢献してまいります。
23年を超えるGMP関連の業務経験を有し、2018年からフリーランスAuditorとして活動しています。経口剤及び注射剤等の監査業務の経験も多く、EU GMP part I 及び II、 米国の21CFR Part 210-211、欧米のGCP規制及び医療機器QMS、分析施設及び治験薬GMP監査についても豊富な経験を有しています。
More than 23 years of professional experience in Quality departments of pharmaceutical industry (both API & Formulation) at various levels. I have started working as freelance auditor and GMP consultant to use my experience in this field since March- 2018. Audited more than 300 pharmaceutical companies including Formulations (Oral dosages and Sterile facilities), API facilities, Advanced Intermediates facilities, Excipients facilities, primary packaging materials, clinical research organizations, Medical devices, Analytical laboratories, distributors, etc.
I have over 30 years of experience in a variety of roles up to Executive Director of Quality Assurance with GE Healthcare with responsibility for 4 global sites with a team of ca. 200. McMahon has extensive knowledge of global regulations for pharmaceutical manufacturing encompassing validation, production, research and development and a comprehensive knowledge of international GLP, GMP, GCP and GDP requirements. I have over 20 years’ experience as a practicing QP across multiple different product types and has been a Principal QP for 10 years. I am a highly experienced technical/medical writer, responsible for preparation and submission of preclinical, Phase I to IV clinical trial reports and manufacturing approval submissions.